FPS
FOLD

Fieldpoint Private Securities’s Amicus Therapeutics FOLD Stock Holding History

Fieldpoint Private Securities’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$110K Sell
10,241
-29
-0.3% -$239 0.03% 344
2022
Q1 		$97K Hold
10,270
– – 0.02% 440
2021
Q4 		$119K Buy
10,270
+3,161
+44% +$35.2K 0.02% 409
2021
Q3 		$68K Hold
7,109
– – 0.02% 504
2021
Q2 		$74K Sell
7,109
-87
-1% -$849 0.02% 486
2021
Q1 		$71K Buy
+7,196
New +$111K 0.02% 475

Other funds holding FOLD

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fieldpoint Private Securities's FOLD Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Amicus Therapeutics (FOLD) stake by 0.28% in Q2 2022, selling an estimated $239 and leaving 10,241 shares worth $110K. The position accounts for 0.03% of the portfolio, ranked #344.

Fieldpoint Private Securities first reported a position in FOLD in Q1 2021 and has held it in 6 quarters since. The position peaked at $119K in Q4 2021. 212 funds tracked by Wall St. Rank hold FOLD as of Q2 2022.

  • Fieldpoint Private Securities held 10,241 shares of Amicus Therapeutics worth $110K as of Q2 2022.
  • Fieldpoint Private Securities sold 29 Amicus Therapeutics shares in Q2 2022, an estimated $239.
  • Amicus Therapeutics made up 0.03% of Fieldpoint Private Securities's portfolio in Q2 2022, its #344 holding.
  • Fieldpoint Private Securities first reported a position in Amicus Therapeutics in Q1 2021 and has held it in 6 quarters since.
  • Fieldpoint Private Securities's Amicus Therapeutics position peaked at $119K in Q4 2021.
  • 212 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.